PARP Inhibitor Biomarkers Testing Product Market by Product Type and Application- Global Industry Analysis & Forecast to 2027
Published On : August 2021 Pages : 158 Category: Medical Devices Report Code : HC0817309
PARP Inhibitor Biomarkers Testing Product Market By Product Type (Testing Kits, Testing Assays) and Application (Hospital, Clinic, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The PARP Inhibitor Biomarkers Testing Product Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.PARP inhibitors are drugs which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitor biomarker is developed for diagnosis and treatment of several diseases, and the most important one is cancer.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global PARP Inhibitor Biomarkers Testing Product Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Myriad Genetics, Inc.
- Hoffmann-La Roche AG
- Invitae Corporation
- NeoGenomics Laboratories, Inc.
- BPS Bioscience, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· PARP Inhibitor Biomarkers Testing Product Market, ByProduct Type, Estimates and Forecast, 2017-2027 ($Million)
o Testing Kits
o Testing Assays
· PARP Inhibitor Biomarkers Testing Product Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Clinic
o Others
· PARP Inhibitor Biomarkers Testing Product Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Myriad Genetics, Inc.
o Hoffmann-La Roche AG
o Invitae Corporation
o NeoGenomics Laboratories, Inc.
o BPS Bioscience, Inc.
· PARP Inhibitor Biomarkers Testing Product Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America PARP Inhibitor Biomarkers Testing Product Market, By Country
o U.S. PARP Inhibitor Biomarkers Testing Product Market
o Canada PARP Inhibitor Biomarkers Testing Product Market
o Mexico PARP Inhibitor Biomarkers Testing Product Market
o Europe
§ Europe PARP Inhibitor Biomarkers Testing Product Market, By Country
· Germany PARP Inhibitor Biomarkers Testing Product Market
o UK PARP Inhibitor Biomarkers Testing Product Market
o France PARP Inhibitor Biomarkers Testing Product Market
o RussiaPARP Inhibitor Biomarkers Testing Product Market
o Italy PARP Inhibitor Biomarkers Testing Product Market
o Rest of Europe PARP Inhibitor Biomarkers Testing Product Market
o Asia-Pacific
§ Asia-Pacific PARP Inhibitor Biomarkers Testing Product Market, By Country
o ChinaPARP Inhibitor Biomarkers Testing Product Market
o Japan PARP Inhibitor Biomarkers Testing Product Market
o South KoreaPARP Inhibitor Biomarkers Testing Product Market
o India PARP Inhibitor Biomarkers Testing Product Market
o Southeast AsiaPARP Inhibitor Biomarkers Testing Product Market
o Rest of Asia-Pacific PARP Inhibitor Biomarkers Testing Product Market
o South America
§ South AmericaPARP Inhibitor Biomarkers Testing Product Market
o Brazil PARP Inhibitor Biomarkers Testing Product Market
o ArgentinaPARP Inhibitor Biomarkers Testing Product Market
o ColumbiaPARP Inhibitor Biomarkers Testing Product Market
o Rest of South America PARP Inhibitor Biomarkers Testing Product Market
o Middle East and Africa
§ Middle East and AfricaPARP Inhibitor Biomarkers Testing Product Market
o Saudi ArabiaPARP Inhibitor Biomarkers Testing Product Market
o UAEPARP Inhibitor Biomarkers Testing Product Market
o EgyptPARP Inhibitor Biomarkers Testing Product Market
o NigeriaPARP Inhibitor Biomarkers Testing Product Market
o South Africa PARP Inhibitor Biomarkers Testing Product Market
o Rest of MEA PARP Inhibitor Biomarkers Testing Product Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. PARP Inhibitor Biomarkers Testing Product Market, By Type
5.1. Introduction
5.2. Global PARP Inhibitor Biomarkers Testing Product Revenue and Market Share by Type (2017-2021)
5.2.1. Global PARP Inhibitor Biomarkers Testing Product Revenue and Revenue Share by Type (2017-2021)
5.3. Testing Kits
5.3.1. Global Testing Kits Revenue and Growth Rate (2017-2021)
5.4. Testing Assays
5.4.1. Global Testing Assays Revenue and Growth Rate (2017-2021)
6. PARP Inhibitor Biomarkers Testing Product Market, By Application
6.1. Introduction
6.2. Global PARP Inhibitor Biomarkers Testing Product Revenue and Market Share by Application (2017-2021)
6.2.1. Global PARP Inhibitor Biomarkers Testing Product Revenue and Revenue Share by Application (2017-2021)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2021)
6.4. Clinic
6.4.1. Global Clinic Revenue and Growth Rate (2017-2021)
6.5. Others
6.5.1. Global Others Revenue and Growth Rate (2017-2021)
7. PARP Inhibitor Biomarkers Testing Product Market, By Region
7.1. Introduction
7.2. Global PARP Inhibitor Biomarkers Testing Product Revenue and Market Share by Regions
7.2.1. Global PARP Inhibitor Biomarkers Testing Product Revenue by Regions (2017-2021)
7.3. North America PARP Inhibitor Biomarkers Testing Product by Countries
7.3.1. North America PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2021)
7.3.2. North America PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe PARP Inhibitor Biomarkers Testing Product by Countries
7.4.1. Europe PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2021)
7.4.2. Europe PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific PARP Inhibitor Biomarkers Testing Product by Countries
7.5.1. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America PARP Inhibitor Biomarkers Testing Product by Countries
7.6.1. South America PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2021)
7.6.2. South America PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa PARP Inhibitor Biomarkers Testing Product by Countries
7.7.1. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Myriad Genetics, Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Hoffmann-La Roche AG
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Invitae Corporation
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. NeoGenomics Laboratories, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. BPS Bioscience, Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
9. PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.1. Global PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. PARP Inhibitor Biomarkers Testing Product Market Forecast by Regions (2022-2027)
9.2.1. North America PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.1.1. United States PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.1.2. Canada PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.1.3. Mexico PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.2. Europe PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.2.1. Germany PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.2.2. France PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.2.3. UK PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.2.4. Russia PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.2.5. Italy PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.2.6. Rest of Europe PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.3. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.3.1. China PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.3.2. Japan PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.3.3. Korea PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.3.4. India PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.3.5. Southeast Asia PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.4. South America PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.4.1. Brazil PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.4.2. Argentina PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.4.3. Columbia PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.4.4. Rest of South America PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.5. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.5.3. Egypt PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.5.4. Nigeria PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.5.5. South Africa PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.5.6. Turkey PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Forecast (2022-2027)
9.3. PARP Inhibitor Biomarkers Testing Product Market Forecast by Type (2022-2027)
9.3.1. PARP Inhibitor Biomarkers Testing Product Forecast by Type (2022-2027)
9.3.2. PARP Inhibitor Biomarkers Testing Product Market Share Forecast by Type (2022-2027)
9.4. PARP Inhibitor Biomarkers Testing Product Market Forecast by Application (2022-2027)
9.4.1. PARP Inhibitor Biomarkers Testing Product Forecast by Application (2022-2027)
9.4.2. PARP Inhibitor Biomarkers Testing Product Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure France PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure China PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure India PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) and Growth Rate (2017-2027)
Table Global PARP Inhibitor Biomarkers Testing Product Revenue and Revenue Share by Type (2017-2019)
Figure Global Testing Kits Revenue and Growth Rate (2017-2019)
Figure Global Testing Assays Revenue and Growth Rate (2017-2019)
Table Global PARP Inhibitor Biomarkers Testing Product Revenue and Revenue Share by Application (2017-2019)
Figure Global Hospital Revenue and Growth Rate (2017-2019)
Figure Global Clinic Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global PARP Inhibitor Biomarkers Testing Product Revenue by Regions (2017-2019)
Figure North America PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure North America PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2019)
Figure North America PARP Inhibitor Biomarkers Testing Product by Countries (2017-2019)
Figure North America PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2019)
Figure United States PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure United States PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Canada PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Mexico PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Europe PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2019)
Figure Europe PARP Inhibitor Biomarkers Testing Product by Countries (2017-2019)
Figure Europe PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2019)
Figure Germany PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Germany PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure France PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure UK PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Russia PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Italy PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Rest of Europe PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific PARP Inhibitor Biomarkers Testing Product by Countries (2017-2019)
Figure Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2019)
Figure China PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure China PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Japan PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Korea PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure India PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Southeast Asia PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Rest of Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure South America PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2019)
Figure South America PARP Inhibitor Biomarkers Testing Product by Countries (2017-2019)
Figure South America PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2019)
Figure Brazil PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Brazil PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Argentina PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Columbia PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Rest of South America PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa PARP Inhibitor Biomarkers Testing Product by Countries (2017-2019)
Figure Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Saudi Arabia PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure United Arab Emirates PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Egypt PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Nigeria PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure South Africa PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Turkey PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa PARP Inhibitor Biomarkers Testing Product Growth Rate (2017-2019)
Figure Rest of Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2017-2019)
Table Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Financial Overview
Table Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Financial Overview
Table Invitae Corporation PARP Inhibitor Biomarkers Testing Product Financial Overview
Table NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Financial Overview
Table BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Financial Overview
Figure Global PARP Inhibitor Biomarkers Testing Product Revenue (Millions USD) and Growth Rate (2019-2027)
Table PARP Inhibitor Biomarkers Testing Product Market Forecast by Regions (2019-2027)
Figure North America PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure United States PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Canada PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Mexico PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Europe PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Germany PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure France PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure UK PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Russia PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Italy PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Rest of Europe PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Asia-Pacific PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure China PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Japan PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Korea PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure India PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Southeast Asia PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Rest of Asia-Pacific PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure South America PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Brazil PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Argentina PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Columbia PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Rest of South America PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Saudi Arabia PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure United Arab Emirates PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Egypt PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Nigeria PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure South Africa PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Turkey PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Rest of Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Forecast (2019-2027)
Figure Global PARP Inhibitor Biomarkers Testing Product Forecast by Type (2019-2027)
Figure Global PARP Inhibitor Biomarkers Testing Product Market Share Forecast by Type (2019-2027)
Figure Global PARP Inhibitor Biomarkers Testing Product Forecast by Type (2019-2027)
Figure Global PARP Inhibitor Biomarkers Testing Product Forecast by Application (2019-2027)
Figure Global PARP Inhibitor Biomarkers Testing Product Market Share Forecast by Application (2019-2027)
Figure Global PARP Inhibitor Biomarkers Testing Product Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|